Search
for
Sort by
Research 181–210 of 333
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- BPH Medications May Increase Risk of Self-Harm, Depression
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- BPH: costs and treatment outcomes.
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review
- Impact of Microbial Infection on Sperm Parameters of Seminal Bacteria in Asymptomatic Subfertile Males
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- No increased risk of CV events with dutasteride vs finasteride
- Treatment options for alopecia: an update, looking to the future
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Association between Insulin Resistance and Hyperandrogenism among Women with PCOS in Pakistan
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
- <i>In vivo</i> and <i>in silico</i> evaluation of the ameliorative effect of hesperidin on finasteride-induced testicular oxidative stress in Wistar rats
- ‘Post-finasteride syndrome’: what to tell our female patients?
- Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS
- Should Finasteride Be Routinely Given Preoperatively for TURP?
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.